From: Good guy or bad guy: the opposing roles of microRNA 125b in cancer
Tumor entity | Direction of deregulation | miR-125b targets | Comments | Ref. |
---|---|---|---|---|
Bladder cancer | Down | E2F3 | Regulator of colony formation, cell division | [49] |
 | Down | MMP13 | Regulator of cell migration and invasion | [50] |
 | Down | NA | NA | [51] |
Breast cancer | Down | EPO, EPOR | Regulator of differentiation and survival of erythroid cells | [52] |
 | Down | ETS1 | Regulator of cell proliferation, clonogenicity and cell cycle progression | [24] |
 | Down | ENPEP, CK2-α, CCNJ, MEGF9 | Cell proliferation and anchorage-independent growth | [53] |
 | Down | ERBB2/ERBB3 | Regulator of migration and invasion | [40] |
 | Down | MUC1 | Regulator of proliferation and apoptosis induction | [54] |
Endometrial cancer | Down | ERBB2 | Regulator of cell invasion | [20] |
Ewing sarcoma | Down | IGF1, IGFR, mTOR, RSK1 | Growth inhibitory properties | [55] |
 | Down | PI3K/Akt/mTOR | Regulator of proliferation, migration and invasion | [56] |
Head and neck tumors | Down | TACSTD2 (TROP2) | Causes mitogen-activated protein kinase pathway dysfunction | [17] |
Hepatocellular carcinoma (HCC) | Down | Bcl-W, Mcl-1, IL-6R | Regulator of apoptosis | |
 | Down | BCL2 | Regulator of apoptosis | [59] |
 | Down | PIGF | Regulator of invasion/angiogenesis | [60] |
 | Down | LIN28B | Regulator of cell migration and invasion | [61] |
 | Down |  | Suppresses the cell growth via Akt phosphorylation | [62] |
Higher in HCCs with good survival | ||||
Oral squamous cell carcinoma | Down | NA | Regulator of proliferation | [21] |
Osteosarcoma | Down | STAT3 | Regulator of proliferation and migration | [22] |
Ovarian cancer | Down | BCL3 | Regulator of proliferation and clonal formation | [63] |
 | Down | HER2/HER3 | Regulator of proliferation and angiogenesis | [64] |
Skin cancer | Down | c-Jun | Regulator of proliferation | [19] |
Thyroid cancer | Down | NA | NA | [29] |